María Julia L. B.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Pharmacokinetics Study Comparing GME751 and US/EU-Approved Pembrolizumab in Stage II and III Melanoma Patients Requiring Adjuvant Therapy
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
- Evaluation of an IDH1m Inhibitor in Patients with IDH1-Mutated Malignancies and Hepatic or Renal Impairment
Data & Insights
Has run more than one trial at 18 of 56 partner sites.
Specializations
Oncology Focus
The investigator specializes in the treatment of advanced solid tumors, with particular emphasis on developing therapeutic approaches for metastatic cancer conditions.
- Solid Tumor Management
- Metastatic Disease Treatment
- Advanced Cancer Care
Their research activities concentrate on investigating novel therapeutic interventions for patients with locally advanced and metastatic solid tumors.
Treatment Development
The investigator is involved in evaluating innovative therapeutic compounds for the treatment of advanced cancers, focusing on both monotherapy and combination approaches.
- Novel Therapeutic Evaluation
- Combination Treatment Strategies
- Dose Optimization Studies
Their work encompasses the assessment of new treatment modalities for patients with progressive solid tumors.
Clinical Expertise
The investigator's clinical focus includes the management of locally advanced malignancies and the development of treatment strategies for metastatic disease progression.
- Advanced Cancer Management
- Progressive Disease Treatment
- Therapeutic Innovation
Their expertise extends to the evaluation of therapeutic interventions for various types of solid tumors in advanced stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.